- Home
- HRMY vs VSTS Comparison
HRMY vs VSTS Comparison
Compare HRMY & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- VSTS
- Stock Information
- Founded
- HRMY 2017
- VSTS 1936
- Country
- HRMY United States
- VSTS United States
- Employees
- HRMY N/A
- VSTS N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- VSTS
- Sector
- HRMY Health Care
- VSTS
- Exchange
- HRMY Nasdaq
- VSTS Nasdaq
- Market Cap
- HRMY 1.8B
- VSTS 773.6M
- IPO Year
- HRMY 2020
- VSTS N/A
- Fundamental
- Price
- HRMY $34.43
- VSTS $6.02
- Analyst Decision
- HRMY Strong Buy
- VSTS Sell
- Analyst Count
- HRMY 9
- VSTS 4
- Target Price
- HRMY $54.44
- VSTS $9.25
- AVG Volume (30 Days)
- HRMY 594.8K
- VSTS 3.1M
- Earning Date
- HRMY 08-05-2025
- VSTS 08-06-2025
- Dividend Yield
- HRMY N/A
- VSTS 1.76%
- EPS Growth
- HRMY 13.13
- VSTS N/A
- EPS
- HRMY 2.62
- VSTS N/A
- Revenue
- HRMY $744,852,000.00
- VSTS $2,731,558,000.00
- Revenue This Year
- HRMY $20.33
- VSTS N/A
- Revenue Next Year
- HRMY $17.67
- VSTS $0.36
- P/E Ratio
- HRMY $13.30
- VSTS N/A
- Revenue Growth
- HRMY 20.62
- VSTS N/A
- 52 Week Low
- HRMY $26.47
- VSTS $5.20
- 52 Week High
- HRMY $41.61
- VSTS $17.83
- Technical
- Relative Strength Index (RSI)
- HRMY 64.26
- VSTS 49.18
- Support Level
- HRMY $33.76
- VSTS $5.85
- Resistance Level
- HRMY $35.08
- VSTS $6.36
- Average True Range (ATR)
- HRMY 0.87
- VSTS 0.25
- MACD
- HRMY 0.34
- VSTS 0.04
- Stochastic Oscillator
- HRMY 92.43
- VSTS 68.75
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About VSTS Vestis Corporation
Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.